Pulsenmore and Clalit Launch $4.5M At-Home IVF Monitoring Service

Event summary

  • Pulsenmore and Clalit Health Services signed a $4.5M five-year deal for at-home follicular monitoring service Pulsenmore FC, following an 18-month pilot.
  • Service will be deployed via Beilinson NEXT, Beilinson Medical Center's virtual hospital, with real-time online guidance and clinical oversight.
  • Pulsenmore FC aims to reduce in-clinic visits for IVF and fertility preservation patients by enabling at-home ultrasound scans with mobile app guidance.
  • Previous clinical study at Beilinson Medical Center showed strong safety profile with high concordance between at-home and in-clinic measurements.

The big picture

This partnership marks a significant step in the shift towards home-based healthcare services, particularly in fertility treatments. Clalit's strategic vision of 'Medicine has left the building' aligns with broader industry trends towards decentralized, patient-centric care models. The $4.5M deal size indicates substantial confidence in the market potential for at-home fertility monitoring solutions.

What we're watching

Market Expansion
Whether Pulsenmore can replicate this success in other markets beyond Israel, given the regulatory and cultural differences in fertility care.
Clinical Adoption
The pace at which other healthcare providers adopt similar at-home monitoring solutions, potentially disrupting traditional fertility clinic models.
Revenue Growth
How this agreement will impact Pulsenmore's top line, considering the $4.5M potential value over five years and the possibility of similar deals with other HMOs.